Neoadjuvant GOLP Boosts Event-Free Survival in High-Risk Intrahepatic Cholangiocarcinoma: NEJM Study Medha Baranwal7 March 2026 8:00 AM ISTChina: A neoadjuvant combination regimen comprising chemotherapy, targeted therapy, and immunotherapy has demonstrated significant clinical benefit in...
Life-changing drug identified for children with rare epilepsy in new research Dr. Kamal Kant Kohli5 March 2026 8:30 PM ISTA new experimental treatment for children with a hard-to-treat form of epilepsy is safe and can reduce seizures dramatically, helping them lead much...
Wireless retinal implant helps blind patients see again: Study Dr. Kamal Kant Kohli4 March 2026 8:00 PM ISTA tiny wireless retinal implant has helped restore central vision in people with advanced age-related macular degeneration (AMD), according to results...
COVID-19 Vaccination Linked to Lower Hospitalization and Death Risk: NEJM Study Aashi verma26 Feb 2026 9:00 PM ISTUSA: The 2024-2025 COVID-19 vaccine was associated with significant reductions in severe clinical outcomes in a national cohort of U.S. veterans....
USFDA Overhauls Drug Approval Process, Moves Away from Two-Study Rule sheeba farhat19 Feb 2026 8:00 PM ISTNew Delhi: The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs, the...
New scan could help millions with hard-to-treat high blood pressure Dr. Kamal Kant Kohli29 Jan 2026 9:00 AM ISTA speedy new scan could improve how millions of people with high blood pressure are treated, suggests a new study led by UCL (University College...
Ianalumab Shows Durable Platelet Response in Primary Immune Thrombocytopenia: NEJM Dr. Kamal Kant Kohli21 Jan 2026 8:15 PM ISTMore than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary...
High-dose antibiotic does not reduce mortality in tuberculous meningitis: Study Dr. Kamal Kant Kohli5 Jan 2026 9:15 PM ISTEach year, 11 million people worldwide develop tuberculosis, and about 1.4 million die from it. Meningitis occurs in 1-2% of patients and is the most...
Gene-Edited CAR-T Delivers New Hope in Deadly T-Cell Leukemia: Research Shows Medha Baranwal2 Jan 2026 8:15 PM ISTLondon: A novel gene-edited immunotherapy has demonstrated encouraging outcomes for children and adults with relapsed or refractory T-cell acute...
One Shot Enough: Major Trial Finds Single HPV Dose Matches Two-Dose Protection: NEJM Medha Baranwal24 Dec 2025 8:30 PM ISTUSA: A major international clinical trial published in the New England Journal of Medicine has delivered encouraging evidence that a single dose of...
Ketamine vs Etomidate: No Difference in 28-Day Mortality in critically ill adults requiring tracheal intubation: NEJM Dr. Kamal Kant Kohli11 Dec 2025 9:00 PM ISTDoctors treating seriously ill patients in an emergency setting may want to give the sedative etomidate, rather than ketamine, while placing a...
Smartphones can monitor patients with neuromuscular diseases, suggests study Dr. Kamal Kant Kohli9 Dec 2025 8:45 PM ISTIn a study published in the New England Journal of Medicine, Delp, a professor of bioengineering, and his collaborators showed that a smartphone could...
